• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Sherry Rais of Enthea Recommends 'Nickel and Dimed: On (Not) Getting By in America' to Readers

News
Video
MHE PublicationMHE September 2023
Volume 33
Issue 9

Sherry Rais, M.Sc., CEO and co-founder, Enthea, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, she recommends "Nickel and Dimed: On (Not) Getting By in America" by Barbara Ehrenreich to not only those in healthcare, but all readers as the book illustrates the ways in which inequality affects people’s access to healthcare.

Sherry Rais, M.Sc., CEO and co-founder, Enthea, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, she recommends "Nickel and Dimed: On (Not) Getting By in America" by Barbara Ehrenreich to not only those in healthcare, but all readers as the book illustrates the ways in which inequality affects people’s access to healthcare.

"It is a powerful book that shows the human cost of inequality and how it can lead to poor health outcome, and it provides a valuable perspective on the challenges that low-wage workers face," Rais said.

Related Videos
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Video 8 - "Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization"
Video 7 - "Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider"
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
© 2024 MJH Life Sciences

All rights reserved.